134 related articles for article (PubMed ID: 37688684)
1. Correction to: Multiparametric analysis of etoposide exposed mesenchymal stem cells and Fanconi anemia cells: implications in development of secondary myeloid malignancy.
Özdemir C; Muratoğlu B; Özel BN; Alpdündar-Bulut E; Tonyalı G; Ünal Ş; Uçkan-Çetinkaya D
Clin Exp Med; 2023 Dec; 23(8):4525. PubMed ID: 37688684
[No Abstract] [Full Text] [Related]
2. Multiparametric analysis of etoposide exposed mesenchymal stem cells and Fanconi anemia cells: implications in development of secondary myeloid malignancy.
Özdemir C; Muratoğlu B; Özel BN; Alpdündar-Bulut E; Tonyalı G; Ünal Ş; Uçkan-Çetinkaya D
Clin Exp Med; 2023 Dec; 23(8):4511-4524. PubMed ID: 37179284
[TBL] [Abstract][Full Text] [Related]
3. An abnormal bone marrow microenvironment contributes to hematopoietic dysfunction in Fanconi anemia.
Zhou Y; He Y; Xing W; Zhang P; Shi H; Chen S; Shi J; Bai J; Rhodes SD; Zhang F; Yuan J; Yang X; Zhu X; Li Y; Hanenberg H; Xu M; Robertson KA; Yuan W; Nalepa G; Cheng T; Clapp DW; Yang FC
Haematologica; 2017 Jun; 102(6):1017-1027. PubMed ID: 28341737
[TBL] [Abstract][Full Text] [Related]
4. Fanconi Anemia Mesenchymal Stromal Cells-Derived Glycerophospholipids Skew Hematopoietic Stem Cell Differentiation Through Toll-Like Receptor Signaling.
Amarachintha S; Sertorio M; Wilson A; Li X; Pang Q
Stem Cells; 2015 Nov; 33(11):3382-96. PubMed ID: 26212365
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic Stem Cell Transplant in Adolescent and Young Adults With Fanconi Anemia Is Feasible With Acceptable Toxicity, With Those Surviving 100 Days Posttransplant Having Excellent Outcomes.
Alhuraiji A; Alzahrani H; Al Mohareb F; Chaudhri N; Alsharif F; Mohamed S; Rasheed W; Aldawsari G; Ahmed SO; Aljurf M
Exp Clin Transplant; 2016 Dec; 14(6):660-664. PubMed ID: 27447289
[TBL] [Abstract][Full Text] [Related]
6. Panniculitis in a 3-year-old child with Fanconi anemia-associated bone marrow hypoplasia heralds transformation to acute myeloid leukemia.
Webber L; Cummins M; Mann R; Shaw L; Ghinai R; Mahon C
Pediatr Dermatol; 2019 Sep; 36(5):725-727. PubMed ID: 31318095
[TBL] [Abstract][Full Text] [Related]
7. Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry.
Rosenberg PS; Alter BP; Ebell W
Haematologica; 2008 Apr; 93(4):511-7. PubMed ID: 18322251
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem/stromal cells from a transplanted, asymptomatic patient with Fanconi anemia exhibit an aging-like phenotype and dysregulated expression of genes implicated in hematopoiesis and myelodysplasia.
Haga CL; Boregowda SV; Booker CN; Krishnappa V; Strivelli J; Cappelli E; Phinney DG
Cytotherapy; 2023 Apr; 25(4):362-368. PubMed ID: 36481320
[TBL] [Abstract][Full Text] [Related]
9. Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production.
Cagnan I; Gunel-Ozcan A; Aerts-Kaya F; Ameziane N; Kuskonmaz B; Dorsman J; Gumruk F; Uckan D
Stem Cell Rev Rep; 2018 Jun; 14(3):425-437. PubMed ID: 29247345
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic correction of Fanconi anemia group C knockout mice.
Gush KA; Fu KL; Grompe M; Walsh CE
Blood; 2000 Jan; 95(2):700-4. PubMed ID: 10627482
[TBL] [Abstract][Full Text] [Related]
11. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
[TBL] [Abstract][Full Text] [Related]
12. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia.
Lensch MW; Tischkowitz M; Christianson TA; Reifsteck CA; Speckhart SA; Jakobs PM; O'Dwyer ME; Olson SB; Le Beau MM; Hodgson SV; Mathew CG; Larson RA; Bagby GC
Blood; 2003 Jul; 102(1):7-16. PubMed ID: 12637330
[TBL] [Abstract][Full Text] [Related]
13. AMD3100 synergizes with G-CSF to mobilize repopulating stem cells in Fanconi anemia knockout mice.
Pulliam AC; Hobson MJ; Ciccone SL; Li Y; Chen S; Srour EF; Yang FC; Broxmeyer HE; Clapp DW
Exp Hematol; 2008 Sep; 36(9):1084-90. PubMed ID: 18495331
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for myeloid malignancy in children with Fanconi anemia.
Mehta PA; Ileri T; Harris RE; Williams DA; Mo J; Smolarek T; Auerbach AD; Kelly P; Davies SM
Pediatr Blood Cancer; 2007 Jun; 48(7):668-72. PubMed ID: 16609946
[TBL] [Abstract][Full Text] [Related]
15. A possible approach for stem cell gene therapy of Fanconi anemia.
Song L
Curr Gene Ther; 2009 Feb; 9(1):26-32. PubMed ID: 19275569
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
[TBL] [Abstract][Full Text] [Related]
17. In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.
van der Heijden MS; Brody JR; Dezentje DA; Gallmeier E; Cunningham SC; Swartz MJ; DeMarzo AM; Offerhaus GJ; Isacoff WH; Hruban RH; Kern SE
Clin Cancer Res; 2005 Oct; 11(20):7508-15. PubMed ID: 16243825
[TBL] [Abstract][Full Text] [Related]
18. Phenotype correction of Fanconi anemia group A hematopoietic stem cells using lentiviral vector.
Yamada K; Ramezani A; Hawley RG; Ebell W; Arwert F; Arnold LW; Walsh CE
Mol Ther; 2003 Oct; 8(4):600-10. PubMed ID: 14529833
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for fanconi anemia.
Croop JM
Curr Hematol Rep; 2003 Jul; 2(4):335-40. PubMed ID: 12901331
[TBL] [Abstract][Full Text] [Related]
20. Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.
Deeg HJ; Socié G; Schoch G; Henry-Amar M; Witherspoon RP; Devergie A; Sullivan KM; Gluckman E; Storb R
Blood; 1996 Jan; 87(1):386-92. PubMed ID: 8547667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
